Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, November 26, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
LATEST ARTICLES
Latest Pharma-News
FDA approved AstraZeneca’s Farxiga(dapagliflozin) for Priority Review for the patients with heart failure with reduced ejection fraction
admin
-
January 8, 2020
0
Other
Want to become a Pharmacist in U.S.? Then follow the journey to registration
admin
-
January 6, 2020
0
Regulatory Affairs
Drug Approval Process in India
admin
-
January 4, 2020
0
Clinical Data Management
ECOG Performance Status
admin
-
January 3, 2020
1
Regulatory Affairs
Orphan Drug Designation in US, EU and Japan
admin
-
December 31, 2019
0
Latest Pharma-News
AVITA medical receives U.S. FDA investigational device exemption approval of clinical feasibility study in order to evaluate Recell system for Vitiligo
admin
-
December 30, 2019
0
Regulatory Affairs
The Drug approval process in EU:
admin
-
December 29, 2019
0
Other
Big Change in FDA process for Biologics:
admin
-
December 29, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved sNDA to Revise Flexion Therapeutic’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA)...
admin
-
December 27, 2019
0
Regulatory Affairs
Biologics Approval Pathways in the USA:
admin
-
December 27, 2019
0
Regulatory Affairs
Generic Products Approval Pathways (USA): Paragraph Certification I, II, III, and IV:
admin
-
December 25, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Allergan’s UBRELVY(ubrogepant) for the acute treatment of migraine with or without aura in adults.
admin
-
December 25, 2019
0
1
...
144
145
146
...
156
Page 145 of 156
Other
What is Decentralized clinical trials?:Benefits and challenges of implementing DCT
September 23, 2024
Navigating the Job Interview: How to Answer the Question, “Why Are You Changing Jobs?”
September 16, 2023
Big Data Analytics: New Possibilities In The Pharmaceutical Industry
November 19, 2021
Causes, Symptoms And Treatment Of Mesothelioma
October 4, 2021
Load more